Gary Gemignani

Gary Gemignani

Financieel Directeur/CFO bij
Solta Medical, Inc.
60 jaar
Health Technology
Consumer Services
Finance

Profiel

Gary G.
Gemignani
currently works at Algorithm Sciences, Inc., as Director from 2021, Laidlaw Venture Partners, as Director from 2021, and Solta Medical, Inc., as Chief Financial Officer & EVP from 2022.
Mr. Gemignani also formerly worked at IASO Pharma, Inc., as Director from 2010 to 2012, Bluejay Diagnostics, Inc., as Independent Director, Gentium Srl, as Chief Financial Officer & Executive Vice President, Biodel, Inc., as Chief Financial Officer from 2014 to 2016, Fortress Biotech, Inc., as Executive VP, Chief Operating & Financial Officer from 2010 to 2011, Champions Oncology, Inc., as Chief Financial Officer & Executive Vice President from 2011 to 2013, Synergy Pharmaceuticals LLC, as Chief Financial Officer & Executive Vice President from 2017 to 2019, Acacia Pharma Group Ltd., as Chief Financial Officer & Executive Vice President from 2020 to 2022, and Albireo Pharma, Inc., as Chief Financial Officer.
Mr. Gemignani received his undergraduate degree in 1987 from Saint Peter's University.

Actieve functies van Gary Gemignani

BedrijvenFunctieBegin
Directeur/Bestuurslid 04-10-2021
Directeur/Bestuurslid 04-10-2021
Financieel Directeur/CFO 01-01-2022

Eerdere bekende functies van Gary Gemignani

BedrijvenFunctieEinde
ACACIA PHARMA GROUP PLC Financieel Directeur/CFO 23-03-2022
SYNERGY PHARMACEUTICALS INC Financieel Directeur/CFO 01-07-2019
CHAMPIONS ONCOLOGY, INC. Financieel Directeur/CFO 30-06-2013
FORTRESS BIOTECH, INC. Financieel Directeur/CFO 26-09-2011
GENTIUM S.P.A. (ADR) Financieel Directeur/CFO 31-03-2010
Ervaring van Gary Gemignani in detail bekijken

Opleiding van Gary Gemignani

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

47

Eerstegraads connecties

13

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit13

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

  1. Beurs
  2. Insiders
  3. Gary Gemignani